Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,277 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects

NCT01856426

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Investigative Site Miami, Florida, United States

Investigative Site San Antonio, Texas, United States

Investigative Site Murray, Utah, United States

Investigative Site Frankfurt, Germany

View Trial Details

Completed

Peripheral Arterial Insufficiency Associated With HIV/AIDS

NCT02264509

Conditions: Acquired Immunodeficiency Syndrome, Arterial Insufficiency, Arterial Occlusive Diseases, +20 more
Locations: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, D.f., Mexico, Mexico

View Trial Details

Completed

Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus

NCT01471574

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: University Of Alabama At Birmingham Birmingham, Alabama, United States

Scripps Clinic La Jolla, California, United States

Southern California Permanente Medical Group Los Angeles, California, United States

Desert Medical Group Inc. Palm Springs, California, United States

View all 86 locations

View Trial Details

Completed

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

NCT01813513

Conditions: Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

NCT01605513

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Phase One Clinical Trial ward, First Hospital, Jilin University Changchun, Jilin, China

View Trial Details

Completed

A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006)

NCT01335607

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

NCT01919125

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)

NCT01907724

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS

NCT02376582

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations: Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI) Entebbe, Uganda

Medical Research Council (MRC) /Uganda Virus Research Institute (UVRI) Masaka, Uganda

View Trial Details

Completed

A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

NCT01157104

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Blood-Borne Infections

Blood-Borne Infections trial results

Related conditions